non-DNMT3A CHIP
Biomarker1 paper1 finding
- Humans1
Associations
1Stage 4 CKM syndrome progression
upin humans1
1 study
Stage 4 CKM syndrome progression
upin humans1
non-DNMT3A CHIP predicts stage 4 CKM syndrome progression in humans (aHR 1.24, 95% CI 1.17-1.31).
Humansmultivariable-adjustedmedian 13.5 yearsn = 451,460
Clonal haematopoiesis and cardiovascular-kidney-metabolic syndrome: a cohort study · European heart journal · 30 Aug 2026
Latest
3medRxivHumansPreprint
ASXL1-mutant clonal hematopoiesis links to aortic valve disease
In cohort data and cell models, ASXL1 mutations tracked with incident aortic stenosis and promoted valvular calcification that was reduced by IL-1 or…In cohort data and cell models, ASXL1 mutations tracked with incident aortic stenosis and promoted valvular calcification that was reduced by IL-1 or IL-6 inhibition.